The University of Utah’s Chemical Engineering Department has partnered with Denali Therapeutics to enhance its Deep Tech Biomanufacturing Program, thanks to the opening of Utah’s first industrial-scale biotherapeutics manufacturing facility. This collaboration is part of the Utah Workforce for Biotherapeutics (UWB) Deep Tech Initiative, which aims to train students in the production of biologics—medicines derived from living cells. The new facility provides students with hands-on experience in sterile biomanufacturing processes, preparing them for careers in the biotech industry and supporting the growth of Utah’s life sciences ecosystem.
Content to show for accordion 1.
Content to show for accordion 2.
Content to show for accordion 3.
Hi THere Fella Her is a link
Learning how to maintain contamination-free environments.
Managing the growth of cells used to produce biologics.
Purifying and packaging the final therapeutic products.


In a real manufacturing environment.
And quality control.
With industry professionals.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Provident ab nulla quod dignissimos vel non corrupti doloribus voluptatum eveniet
read moreLorem ipsum dolor sit amet consectetur adipisicing elit. Provident ab nulla quod dignissimos vel non corrupti doloribus voluptatum eveniet
read moreLorem ipsum dolor sit amet consectetur adipisicing elit. Provident ab nulla quod dignissimos vel non corrupti doloribus voluptatum eveniet
read moreThis initiative is part of a broader effort by the Utah System of Higher Education (USHE) to develop a skilled workforce in biomanufacturing. The “Deep Tech” label refers to technologies that are complex, science-driven, and have long development cycles—like biologics. The UWB program is designed to give students practical, hands-on experience in producing these advanced therapies, which are typically made using living cells and require sterile, tightly controlled environments.
